Previous 10 | Next 10 |
It's hard to think of an industry that was more impacted by the 2020 COVID pandemic than diagnostics. The often-overlooked part of the healthcare system sprang into action, testing more than 250 million people last year in the U.S. alone. And interestingly, some testing companies performed ...
In my 2020 outlook, which was pre-coronavirus, I argued the case for buying small and microcap medical stocks that were priced for "non-success". This approach worked in 2020. My 2020 themes were gene therapy, targeted oncologics, and less invasive surgery. For 2021, I add SARS CoV-2 ...
CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in th...
Image source: The Motley Fool. GenMark Diagnostics Inc (NASDAQ: GNMK) Q3 2020 Earnings Call Oct 28, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: GenMark Diagnostics Inc (GNMK) Q3 2020 Earnings Call Transcript
GenMark Diagnostics, Inc. (GNMK) Q3 2020 Earnings Conference Call October 28, 2020, 04:30 PM ET Company Participants Leigh Salvo - Investor Relations, Gilmartin Group LLC Scott Mendel - President and Chief Executive Officer Johnny Ek - Chief Financial Officer Conference Call Participants Ryan...
CARLSBAD, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended September 30, 2020. Third Quarter 2020 Highligh...
Gainers: [[APTX]] +89.3%. [[EMKR]] +14.8%. [[GNMK]] +8.9%. [[CCK]] +6.5%. [[NOK]] +3.8%.Losers: [[RAIL]] -9.6%. [[HXL]] -8.8%. [[BLU]] -6.9%. [[STLD]] -3.4%. [[TEO]] -3.3%. For further details see: APTX, GNMK, HXL and RAIL among after-hours movers
CARLSBAD, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Wednesday, October 28, 2020. Management will hold a conference call to review the company's fin...
GenMark guided to a meaningfully better quarter than the sell-side had expected, with revenue about 12% higher than the average sell-side estimate and strong ePlex system placements. The market may be moving on, assuming that antigen-based testing will become the dominant approach for...
Medigus (MDGS) +32% on buy out of Amazon Marketplace brands.MicroVision (MVIS) +25%.Just Energy Group (JE) +23%. after PIMCO disclosed 28.9% stake in the company.Xilinx (XLNX) +16% as AMD in advance talks to buy the company.Extreme Networks (EXTR) +17% ...
News, Short Squeeze, Breakout and More Instantly...
GenMark Diagnostics Inc. Company Name:
GNMK Stock Symbol:
NASDAQ Market:
GenMark Diagnostics Inc. Website:
NEW YORK, NY / ACCESSWIRE / April 9, 2021 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New ...
Healthcare giant Roche Holding (OTC: RHHBY) recently announced plans to acquire GenMark Diagnostics (NASDAQ: GNMK) in a deal valued at around $1.8 billion. The news sent GenMark's shares soaring close to 30%. In this Motley Fool Live video, recorded on March 17 , Mot...
USA News Group / In the wake of the US presidential election, calls for economies to reopen are beginning to mount from governors such as Andrew Cuomo in New York and Gavin Newsom in California , and mayors like Chicago’s Lori Lightfoot. As regulators contemplate the ...